Gradient Investments LLC: JEF position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Gradient Investments LLC on JEF, newest first. How the timeline and the estimate are built.
Gradient Investments LLC held 351,573 JEF shares at 2026-09-30 per its 13F-HR filed 2026-10-08.
the latest 13F is the newest step
- period ended2026-09-3013F 351,573 sharesChange vs previous 13F +42,679 shares
0.23% of the 13F portfolio, value $16,077,418.
13F-HR 0001542265-26-000006 filed by Gradient Investments LLC
Accepted , ingested - period ended2026-06-3013F 308,894 sharesChange vs previous 13F +7,453 shares
0.21% of the 13F portfolio, value $15,438,505.
13F-HR 0001542265-26-000005 filed by Gradient Investments LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2026-03-3113F 301,441 sharesChange vs previous 13F +9,661 shares
0.19% of the 13F portfolio, value $12,440,471.
13F-HR 0001542265-26-000003 filed by Gradient Investments LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-12-3113F 291,780 sharesChange vs previous 13F +259,615 shares
0.29% of the 13F portfolio, value $18,081,631.
13F-HR 0001542265-26-000001 filed by Gradient Investments LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-09-3013F 32,165 sharesChange vs previous 13F -4,445 shares
0.04% of the 13F portfolio, value $2,104,234.
13F-HR 0001542265-25-000007 filed by Gradient Investments LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-06-3013F 36,610 sharesChange vs previous 13F not available
0.04% of the 13F portfolio, value $2,002,201.
13F-HR 0001542265-25-000004 filed by Gradient Investments LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).